Lelieveld, Paul (Stichting Participatie Atriva 201702 Director + Meneldor 201806 Co-Founder) |
Investment Manager |
Stichting Participatie Atriva (Foundation Participation Atriva) |
Netherlands |
Leitzke, Achim (Macherey-Nagel 201902 General Manager Sales + Marketing) |
Sales Manager / Marketing Manager |
Macherey-Nagel GmbH & Co KG |
Germany |
Leitner, Michael (Public Health PR 201009 Managing Director) |
Managing Director |
Public Health PR-Projektgesellschaft mbH |
Austria |
Leistner, Hermann (Stratec Biomedical Systems –201103 CEO + Founder retired 3/11) |
Chief Executive Officer (CEO) |
Stratec (Group) |
Germany |
Leiss, Florian (Ultivue 202211 VP Product Strategy + Corp Development formerly Definiens) |
Public Relations Manager / Investor Relations Manager |
Ultivue Inc. |
Germany |
Leisner, Christian (CDR-Life 202204 CEO) |
Chief Executive Officer (CEO) |
CDR-Life AG |
Switzerland |
Leino, Lasse (DelSiTech 201609 CEO) |
Chief Executive Officer (CEO) |
DelSiTech Ltd. (FI) |
Finland |
Lein, Jens (KWS Saat 201412) |
n. a. |
KWS Saat (Group) |
Germany |
Leiminger, Roland (Biocrates 20130923 Sr Medical Advisor Diagnostics) |
Sales Manager / Marketing Manager |
Biocrates (Group) |
Austria |
Leimer, Axel (Leimer Industry Consulting 200603) |
n. a. |
Hessen (Hesse) (govt region) |
Germany |
Leimer, Axel (AMSilk 201103 Managing Director) |
Managing Director |
AMSilk GmbH |
Germany |
Leikert, Christian (Carma Fund 202206– General Partner before Creathor Ventures + Future Capital) |
Partner (venture partner) |
Carma Fund (Group) |
Germany |
Leigh, Darin (Mainz Biomed 202204– CCO before CDR Health + Metabolon + Asuragen + Luminex + Abbott) |
Chief Commercial Officer (CCO) |
Mainz Biomed N.V. (Nasdaq: MYNZ) |
Germany |
Leidenberger, Freimut |
n. a. |
BioAgency AG |
Germany |
Leiden, Jeffrey M. (Vertex 20212– CEO before Clarus Ventures + Abbott) |
Chief Executive Officer (CEO) |
Abbott (Group) |
United States (USA) |
Leibinger, Wolfgang (Qiagen –200702– Global Business Director Automated Systems) |
Business Development Manager / Strategy Manager |
Qiagen (Group) |
Germany |
Leibinger, Peter (Germany (govt) 202211 Chair of Supervisory Board at Sprind GmbH) |
Supervisory Board Member |
Germany (govt) |
Germany |
Leibfritz, Dieter (Univ Bremen 200906 Prof Dept Biology/Chemistry Chair for Instrumental Analytics) |
Professor |
University of Bremen |
Germany |
Lehuu, Bertrand (BioXell 200703– CBO before 25y pharma industry incl Global Licensing Director at Roche in Basel) |
Chief Business Officer (CBO) |
Cosmo Pharmaceuticals (Group) |
Italy |
Lehtonen, Tommi (Hedera Dx 202209 CEO + +Co-Founder before Blueprint Genetics 201707 CEO) |
Chief Executive Officer (CEO) |
Hedera Dx S.A. |
Switzerland |
Lehrke, Ingo (Algiax Pharmaceuticals 2019– CEO + Tubulis 202007 CBO) |
Chief Executive Officer (CEO) |
Algiax Pharmaceuticals GmbH |
Germany |
Lehrach, Hans (Max Planck Professor MPI for Molecular Genetics) |
Professor |
Max Planck Society for the Advancement of Science |
Germany |
Lehner, Oliver (AstraZeneca 201809 VP Business Development + Partnering at Definiens AG) |
Business Development Manager / Strategy Manager |
AstraZeneca (Group) |
Germany |
Lehn, Jean-Marie (Therascope founder) |
Company Founder |
Amgen (Group) |
Germany |
Lehmann, Wolf Dieter (Helmholtz 201007 Professor DKFZ GPCF Mass Spectrometry Group) |
Professor |
Helmholtz-Gemeinschaft (HGF) (Group) |
Germany |
Lehmann, Thomas |
n. a. |
Brandenburg (govt region) |
Germany |
Lehmann, Rainer (Sartorius 201703–202310 CFO before SVP Business Processes Unit LEFT 11/24) |
Chief Financial Officer (CFO) |
Sartorius (Group) |
Germany |
Lehmann, Martin (Metabolomic Discoveries 201102 Senior Scientist) |
Researcher (industry) |
Metabolon (Group) |
Germany |
Lehmann, Marc (SmartDyeLivery GmbH 20602 Managing Director) |
Managing Director |
SmartDyeLivery GmbH |
Germany |
Lehmann, Klaus (High-Tech Gründerfonds 201501) |
n. a. |
High-Tech Gründerfonds (HTGF) (Group) |
Germany |
Lehmann, Jonas (Venneos 2014– Co-Founder) |
Company Founder |
Venneos GmbH |
Germany |
Lehmann, Holger (Merck (US) 201502 Head Drug Discovery at MSD Animal Health) |
Research & Development Manager |
Merck (US) (MSD) (Group) |
|
Lehmann, Heike (Insilico Biotechnology 201206 Public Relations) |
Public Relations Manager / Investor Relations Manager |
Yokogawa (Group) |
Germany |
Legrain, Pierre (HUPO 201109 Vice President HUPO) |
HUPO (Human Proteome Organisation) |
HUPO (Human Proteome Organisation) |
Canada |
Legorreta, Pablo (Royalty Pharma 202006 CEO + Founder) |
Chief Executive Officer (CEO) |
Royalty Pharma (Group) |
United States (USA) |
Leggewie, Christian (Evocatal 201306 CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Advanced Enzyme Technologies (Advanced Enzymes) (Group) |
Germany |
Legg, Ben (Centogene 202004 Corporate Communications) |
Public Relations Manager / Investor Relations Manager |
Centogene (Group) |
Germany |
Leewe, Jörn (Novumed 2003–201004– Managing Director + Founder before Boston Consulting Munich) |
Managing Director |
Novumed / Effimed (Group) |
Germany |
Leenders, Frank (Celares GmbH 201507 Managing Director of Operations + Co-Founder) |
Managing Director |
Biosynth (since 9/22) (Group) |
Germany |
Leemhuis, Michel (Kadans Science Partner 202011 CEO) |
Chief Executive Officer (CEO) |
Axa (Group) |
Netherlands |
Lee-Chin, Michael (Portland Holdings 202106 Chairman + Founder) |
Board member, executive |
Portland Holdings |
|
Lee, Young-Ae (Charité 201402– Professor for molecular pediatric allergology) |
Professor |
Humboldt University Berlin |
Germany |
Lee, Sung (MorphoSys 202102–202303 CFO before Sangamo + Gilead Sciences LEFT 3/23) |
Chief Financial Officer (CFO) |
MorphoSys (Group) |
Germany |
Lee, Seong-Wook (Rznomics 202010 CEO + Founder + Prof at Donkook Univ) |
Chief Executive Officer (CEO) |
Rznomics Inc. (KR) |
Korea, Republic of |
Lee, Rosy (Thermo Fisher 201510 VP + General Manager of Human Identification) |
General Manager (management) |
Thermo Fisher (Group) |
United States (USA) |
Lee, Milton (Ballista Inc 201007 Managing Director) |
Managing Director |
Stratec (Group) |
United States (USA) |
Lee, Mike (Redmile Group 201801 Portfolio Manager + Co-Founder) |
Investment Manager |
Redmile Group LLC |
United States (USA) |
Lee, Michael (Syngenta 201809 Director at Syngenta Ventures) |
Investment Manager |
Syngenta (Group) |
|
Lee, Jung Hee (Yuhan 201907 CEO of Yuhan Corp) |
Chief Executive Officer (CEO) |
Yuhan Corporation (Yu Han) (000100:KS) |
Korea, Republic of |
Lee, Denise (Metronomia Clinical Research GmbH 202007– Managing Director before Allergy Therapeutics) |
Managing Director |
Metronomia Clinical Research GmbH |
Germany |
Lee, Chan (BeiGene 202207– General Counsel before Sanofi + Pfizer) |
General Counsel / Chief Legal Officer (CLO) |
BeiGene (Group) |
China |
Lee, Carol (Affect Inc 201412) |
Public Relations Manager / Investor Relations Manager |
Affect Inc. |
United States (USA) |
Lee, Bill (Gilead Sciences 201806 EVP Research) |
Research & Development Manager |
Gilead Sciences (Group) |
United States (USA) |
Ledig, Matthias |
n. a. |
Capgemini (Group) |
Germany |
Leder, Günther (Culavis 2007 Managing Director) |
Chief Executive Officer (CEO) |
Culavis GmbH |
Germany |
Leder, Ethan D. (Precision for Medicine 2012– Executive Chairman + Co-Founder before United BioSource 200312 founder) |
Company Founder |
Precision Medicine Group (Group) |
United States (USA) |
Leber, Alexander (iAtros GmbH 202003 Managing Director + Co-Founder) |
Managing Director |
iAtros GmbH |
Germany |
Lebeaut, Alexandre (Ipsen 201811 EVP RnD + CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Ipsen (Group) |
France |
Leanderson, Tomas (Active Biotech 2008–201706 CEO joined 1999 LEFT 7/17) |
Chief Executive Officer (CEO) |
Active Biotech (Group) |
Sweden |
Le Meunier, Ludovic (Alcen 202402 CEO of Theryq) |
Chief Executive Officer (CEO) |
Alcen (Group) |
France |
Le Brun, Stéphane(Innopsys 201303 CEO + Financial Director) |
Chief Executive Officer (CEO) |
Innopsys (Group) |
France |
Lazarus, Tadd S. (Qiagen 201301– CMO based in US before at Gen-Probe CMO) |
Chief Medical Officer (CMO) |
Qiagen (Group) |
United States (USA) |
Laxhuber, Ludwig A. |
n. a. |
Infineon (Group) |
Germany |
Lawton, Vincent (Merck (US) former Managing Director of Merck Sharp & Dohme UK + VP MSD Europe) |
Managing Director |
Merck (US) (MSD) (Group) |
United Kingdom (GB) |
Lawson, Jennifer (Sartorius 201901 Product Manager for Testing at Sartorius Stedim BioOutsource) |
Product Manager (personnel) |
Sartorius (Group) |
United Kingdom (GB) |
Lawrence, David (Valneva 201708– CFO before Acambis + Chiron Vaccines + GSK) |
Chief Financial Officer (CFO) |
Valneva (Group) |
France |
Lawlor, Bridie (FTI Consulting 202004) |
Public Relations Manager / Investor Relations Manager |
FTI Consulting (Group) |
United States (USA) |
Law, Richard (Exscientia 202101– EVP Strategic Alliances before Evotec + UCSD + LLNL) |
Business Development Manager / Strategy Manager |
Exscientia (Group) |
United Kingdom (GB) |
LaVoie, Donna L. (LaVoieHealthScience 201812 CEO) |
Chief Executive Officer (CEO) |
LaVoieHealthScience (LHS) |
United States (USA) |
Lavino, Francesco Maria (F2G 202104– CEO before Nabriva Therapeutics + Merck (US) + Cubist Pharmaceuticals) |
Chief Executive Officer (CEO) |
F2G (Group) |
United Kingdom (GB) |
Lavin, Mary (Sartorius 202109 President of Sartorius North America) |
President/Director/Head Business Group/Unit/Division |
Sartorius (Group) |
Germany |
Laverty, Hugh (Innovative Medicines Initative 201704 Head of Scientific Operations) |
Cluster Manager |
Innovative Health Initiative (IHI JU) |
EU (European Union) |
Lautscham, Georg (Protagen 201610– CEO before CBO) |
Chief Executive Officer (CEO) |
Freenome (Group) |
Germany |
Lautner, Christian (Heal Capital 202306 Founding Managing Partner + Eternity.Health 202107 MD + Co-Founder) |
Managing Director |
Heal Capital (Heal.Capital) (Group) |
|
Lauterbach, Verena (CureVac GmbH 201603 Senior Director Communications) |
Public Relations Manager / Investor Relations Manager |
CureVac (Group) |
Germany |
Lauterbach, Enise (Lemoa 202003– Managing Director + Founder) |
Managing Director |
Lemoa (Group) |
Germany |
Lauterbach, Anja (Potsdam Science Park 202305 Office Management) |
Public Relations Manager / Investor Relations Manager |
Potsdam Science Park (Standortmanagement Golm GmbH) |
Germany |
Lauter, Frank-Roman (Signature Diagnostics 200601– before Indivumed before GeneScan Europe before founde BioInside GmbH) |
n. a. |
Roche (Group) |
Germany |
Laurer, Christian (Niederösterreich (govt) 200511 Senior Investment Manager at Tecnet Equity) |
Investment Manager |
Niederösterreich (govt region) |
Austria |
Laurent, Jérémie (Astraveus 202306 CEO + Founder) |
Chief Executive Officer (CEO) |
Astraveus S.A.S. |
France |
Laukien, Jörg C. (Bruker –201811 Board Member RETIRED 11/18) |
Board member, non-executive |
Bruker (Group) |
United States (USA) |
Laukien, Günther (Bruker founder) |
Company Founder |
Bruker (Group) |
United States (USA) |
Laukien, Frank H. (Bruker 201204 President + CEO) |
Chief Executive Officer (CEO) |
Bruker (Group) |
United States (USA) |
Laughman, Keith (Viewics 201711 CEO) |
Chief Executive Officer (CEO) |
Roche (Group) |
United States (USA) |
Laugel, Thierry (Kurma Life Sciences Partners 201103 Managing Partner at Kurma BioFund before AGF Private Equity) |
Managing Partner (investment firm) |
Eurazeo (Group) |
France |
Laue, Hans-Jörg (Thermolinear 201006 Managing Director + Co-owner) |
Managing Director |
Thermolinear Isotopenmassenspektrometer GmbH |
Germany |
Laue, Carsten (Medipol 201108 Managing Director) |
Managing Director |
Medipol S.A. |
Switzerland |
Lauber, Wendy (Tecan 201109 Head Product Management for Liquid Handling + Consumables) |
Product Manager (personnel) |
Tecan (Group) |
Switzerland |
Latz, Eicke (Charité Berlin + DRFZ Berlin 202305– + Co-Founder of several companies + Univ Bonn) |
Professor |
Humboldt University Berlin |
Germany |
Latrille, Frank (Merck Serono 200701 Head of Product Development) |
n. a. |
Merck (DE) (Group) |
Switzerland |
Lata, Vlad (Avi Medical 202204 Managing Director (CEO) + Co-Founder) |
Managing Director |
Avi Medical (Group) |
Germany |
Last, Andrew J. (Andy) (Bio-Rad 201904– COO before Berkeley Lights + Intrexon + Affymetrix + BD Biosciences) |
Chief Operating Officer (COO) |
Bio-Rad (Group) |
United States (USA) |
Lassen, Cheryl (Cytos Biotechnology 201303– VP Clinical Development before Novartis + BMS + Abbott + Pharmacia) |
Clinical Research Manager |
Kuros (Group) |
Switzerland |
Laser, Bernd (InProcess Instruments + Vacutec 200908 Managing Director + Founder) |
Managing Director |
InProcess Instruments Gesellschaft für Prozessanalytik mbH (IPI) |
Germany |
Larsen, Philip (Bayer 202121 SVP + Global Head of Research + Early Development before Sanofi 201508 VP) |
Research & Development Manager |
Bayer (Group) |
Germany |
Lapray, Damien (Hedera Dx 202210 CCO + Co-Founder before Sophia Genetics) |
Chief Commercial Officer (CCO) |
Hedera Dx S.A. |
Switzerland |
Lappe, Mark (Inhibrx 201110 CEO + co-founder) |
Chief Executive Officer (CEO) |
Inhibrx Inc. (INBX) |
United States (USA) |
LaPointe, Lawrence (Clinical Genomics 201708 CEO) |
Chief Executive Officer (CEO) |
Clinical Genomics (Group) |
Australia |
Laplace, Frank (BMBF 200703) |
n. a. |
Germany (govt) |
Germany |
Lapid, Henit (Lonza 202104 Head Mammalian Commercial Development + Marketing) |
Sales Manager / Marketing Manager |
Lonza (Group) |
Switzerland |